FAQ

Pulmonary Surfactant-Associated Protein D

Known as: Pulmonary Surfactant Associated Protein D, Lung Protein D, Surfactant pulmonary-associated protein D 
An abundant pulmonary surfactant-associated protein that binds to a variety of lung pathogens and enhances their opsinization and killing by… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-2017
01219872017

Related topics

Related topics

13 relations
In BloodProcess of secretionSFTPD geneSurfactant protein D measurement
(More)

Broader (1)

Pulmonary Surfactants

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Pulmonary Surfactant-Associated Protein D
physiological aspects
agonists
Pulmonary Surfactants
chemical synthesis
standards characteristics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Lung remodeling in aging surfactant protein D deficient mice.
Pulmonary surfactant, a mixture of lipids and proteins at the air-liquid interface of alveoli, prevents the lungs from collapsing… (More)
  • table 2
Is this relevant?
2015
2015
SP-D, KL-6, and HTI-56 levels in children with mycoplasma pneumoniae pneumonia.
UNLABELLED The study was aimed to evaluate the potential biomarkers from pulmonary surfactant protein D (SP-D), Krebs von den… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2015
2015
Reproducibility of biomarkers in induced sputum and in serum from chronic smokers.
RATIONALE Soluble inflammatory markers obtained from non-invasive airway sampling such as induced sputum may be useful biomarkers… (More)
Is this relevant?
Review
2014
Review
2014
Comparative Evaluation of Heterologous Production Systems for Recombinant Pulmonary Surfactant Protein D
Commercial surfactant products derived from animal lungs are used for the treatment of respiratory diseases in premature neonates… (More)
  • figure 1
Is this relevant?
2011
2011
Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations.
Pulmonary alveolar proteinosis (PAP) is a syndrome characterised by accumulation of surfactant in alveoli resulting in… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1997
1997
Surfactant proteins and stable microbubbles in tracheal aspirates of infants with respiratory distress syndrome: relation to the degree of respiratory failure and response to exogenous surfactant
 Surfactant proteins (SP-A and SP-BC), albumin (ALB), and stable microbubble (SM) count were measured in tracheal aspirates from… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
1996
1996
Surfactant abnormalities in infants with severe viral bronchiolitis.
To determine whether abnormalities of pulmonary surfactant occur in infants with acute viral bronchiolitis, surfactant indices… (More)
Is this relevant?
1990
1990
Surfactant abnormalities and adult respiratory failure
Surfactant abnormalities have been implicated in the development of the acute respiratory distress syndrome in adults… (More)
  • table 2
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1988
1988
Response to bovine surfactant (surfactant TA) in two different HMD models (lambs and baboons)
The responses of Surfactant TA instillation in two groups of premature lambs (Group I, 124.8±1.1 days and Group II, 132.2±1.2… (More)
  • table 1
  • figure 1
  • figure 4
Is this relevant?
1987
1987
Effects of maternal treatment with corticosteroids, T3, TRH, and their combinations on lung function of ventilated preterm rabbits with and without surfactant treatments.
Pregnant does were treated with betamethasone, T3, TRH, or combinations of betamethasone plus T3 or TRH using doses of each agent… (More)
Is this relevant?